Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Dow
Healthtrust
Fuji
Johnson and Johnson
Farmers Insurance
Merck
Colorcon
US Department of Justice

Generated: December 10, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FERRIC CARBOXYMALTOSE

« Back to Dashboard

Clinical Trials for Ferric Carboxymaltose

Trial ID Title Status Sponsor Phase Summary
NCT00548691 Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients Completed Luitpold Pharmaceuticals Phase 3 The Objective of this study is to study the safety of FCM in patients with anemia caused by chronic kidney failure
NCT00548860 Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients Completed Luitpold Pharmaceuticals Phase 3 The Objective of this study is to study the safety of FCM in patients with anemia caused by Heavy Uterine Bleeding and the Post Partum state.
NCT00703937 Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia Completed Luitpold Pharmaceuticals Phase 3 The objective of this study is to evaluate the safety of FCM in patients with anemia who are not dialysis dependent.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Ferric Carboxymaltose

Condition Name

Condition Name for Ferric Carboxymaltose
Intervention Trials
Anemia 17
Iron Deficiency 16
Iron Deficiency Anemia 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ferric Carboxymaltose
Intervention Trials
Anemia, Iron-Deficiency 53
Anemia 38
Deficiency Diseases 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ferric Carboxymaltose

Trials by Country

Trials by Country for Ferric Carboxymaltose
Location Trials
United States 55
Germany 20
Spain 12
United Kingdom 8
Switzerland 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ferric Carboxymaltose
Location Trials
Pennsylvania 10
Texas 5
Florida 4
Massachusetts 3
Maryland 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ferric Carboxymaltose

Clinical Trial Phase

Clinical Trial Phase for Ferric Carboxymaltose
Clinical Trial Phase Trials
Phase 4 29
Phase 3 30
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ferric Carboxymaltose
Clinical Trial Phase Trials
Recruiting 28
Completed 26
Not yet recruiting 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ferric Carboxymaltose

Sponsor Name

Sponsor Name for Ferric Carboxymaltose
Sponsor Trials
Luitpold Pharmaceuticals 19
Vifor Inc. 14
Vifor Pharma 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ferric Carboxymaltose
Sponsor Trials
Other 70
Industry 61
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
US Army
Cerilliant
Cantor Fitzgerald
Colorcon
QuintilesIMS
UBS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.